Taken together, these data support that, similar to IL-1α and HMGB1 (ref. 71), IL-33 has a dual function in glioma by acting as both a pro-inflammatory cytokine and an intracellular nuclear factor, functions required to drive glioma progression. Here, IL1A is linked to central nervous system cancer.